✦ LIBER ✦

Potential of Neoadjuvant Trials to Support Drug Approval in High-Risk Early Breast Cancer

✍ Scribed by Cortazar, Patricia; Zhang, Lijun; Prowell, Tatiana

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The potential risk of neoadjuvant chemot

✍ Susanne Taucher; Guenther G. Steger; Raimund Jakesz; Christoph Tausch; Viktor We 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 252 KB

Effect of adding gefitinib to neoadjuvan

✍ Mogens Bernsdorf; Christian Ingvar; Leif Jörgensen; Malgorzata K. Tuxen; Erik H. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 209 KB

Time to include high-risk early ovarian

✍ Ignace Vergote; Frederic Amant 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Pegfilgrastim supports delivery of FEC-1

✍ G. Romieu; M. Clemens; R. Mahlberg; P. Fargeot; M. Constenla; M. Schütte; V. Eas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Prognostic significance of RACGAP1 mRNA

✍ K. Pliarchopoulou, K. T. Kalogeras, R. Kronenwett… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 321 KB

A randomised controlled trial of a pilot

✍ Suzanne E. Scott; Mahrukh Khwaja; Emma L. Low; John Weinman; Elizabeth A. Grunfe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 338 KB